Found 26 matching trials
Risedronate in the Prevention of Osteoporosis in Postmenopausal Women PHASE4 Primary Objective:
* To demonstrate that risedronate 35-mg once weekly is ...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis PHASE3 Two year study to determine the safety and efficacy of weekly 35 mg Risedro...
Show More Learn More & Join Trial
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery PHASE3 The purpose of this research study is to see whether receiving a bisphospho...
Show More Location
Wake Forest School of Medicine
Learn More & Join Trial
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer PHASE3 Prostate cancer patients treated with LHRH agonists (e.g., leuprolide) lose...
Show More Location
Southern Interior Medical Research Corporation
Learn More & Join Trial
A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) PHASE3 This study is to evaluate and compare the effects of Alendronate and Risedr...
Show More Location
Multiple Locations
Learn More & Join Trial
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study) NA The purpose of this study is to evaluate the effectiveness of once weekly r...
Show More Location
University of Pittsburgh Medical Center (GCRC)
Learn More & Join Trial
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use PHASE4 The purpose of the study is to learn if one year of treatment with parathyr...
Show More Location
UC Davis General Medicine Research Clinic
Learn More & Join Trial
A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets PHASE2 The present phase II/III, multicenter, randomized, double-blind, parallel g...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer PHASE3 Aromatase inhibitor therapy is in France the adjuvant reference treatment f...
Show More Location
Service de Rhumatology et de Pathologie Osseuse, Hôpital Edouard Herriot
Learn More & Join Trial
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. PHASE1 Patients with kidney failure have underlying bone disease at the time of tr...
Show More Location
Montefiore Medical Center
Learn More & Join Trial